Intestinal drug transport enhancement by Aloe vera

Planta Medica

Volumn 75, Issue 6, 2009, Pages 587-595

  Chen, Weiyang ^a   Lu, Zhilei ^a   Viljoen, Alvaro ^a   Hamman, Josias ^a  

^a TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Absorption enhancement; Aloe vera (L.) Burm. f.; Asphodelaceae; Caco 2; Gel; Whole leaf extract

Indexed keywords

ALOE VERA EXTRACT; GLUCOSE; INSULIN; LACTIC ACID; MALIC ACID;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG TRANSPORT; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTESTINE; INTESTINE ABSORPTION; NONHUMAN; PLANT LEAF; TIGHT JUNCTION;

ALOE; BIOLOGICAL TRANSPORT; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; HUMANS; INSULIN; INTESTINAL ABSORPTION; PERMEABILITY; PLANT EXTRACTS; PLANT LEAVES; TIGHT JUNCTIONS;

ALOE VERA; ASPHODELACEAE;

EID: 68949112556     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185341     Document Type: Article

References (25)

1. Crowley PJ, Martini LG. Formulation design: new drugs from old. Drug Discov Today 2004; 1: 537-542 (Pubitemid 40197602)
2. Gomez-Orellana I. Strategies to improve oral drug bioavailability. Expert Opin Drug Deliv 2005; 2: 419-433 (Pubitemid 41683218)
3. Muranishi S. Absorption enhancers. Crit Rev Ther Drug Carrier Syst 1990; 7: 1-33
4. Salama NN, Eddington ND, Fasano A. Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev 2006; 58: 15-28
5. Brayden DJ, O'Mahony DJ. Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines. Pharm Sci Technol Today 1998; 1: 291-299
6. Newton LE. Aloes in habitat. In: Reynolds T, ed. Aloes: the genus Aloe. Washington DC: CRC Press; 2004: 3-36
7. Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. J Ethnopharmacol 1999; 68: 3-37 (Pubitemid 29502456)
8. Mascolo N, Izzo AA, Borrelli F, Capasso R, Di Carlo G, Sautebin L, Capasso F. Healing powers of aloes. In: Reynolds T, ed. Aloes: the genus Aloe. Washington DC: CRC Press; 2004: 209-238
9. Talmadge J, Chavez J, Jacobs L, Munger C, Chinnah T, Chow JT,Williamson D, Yates K. Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity. Int Immunopharmacol 2004; 4: 1757-1773 (Pubitemid 39504817)
10. Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera. J Environ Sci Health C 2006; 24: 103-154
11. Femenia A, Sanchez ES, Simal S, Rosello C. Compositional features of polysaccharides from Aloe vera (Aloe barbadensis Miller) plant tissues. Carbohydr Polym 1999; 39: 109-117
12. Lee JK, Lee MK, Yun YP. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int Immunopharmacol 2001; 1: 1275-1284
13. Moreira LRS, Filho EXF. An overview of mannan structure and mannandegrading enzyme systems. Appl Microbiol Biotechnol 2008; 79: 1-14
14. Choi S, Chung M-H. A review on the relationship between Aloe vera components and their biologic effects. Semin Integr Med 2003; 1: 53-62 (Pubitemid 39345210)
15. Ni Y, Turner D, Yates KM, Tizard I. Isolation and characterisation of structural components of Aloe vera L. leaf pulp. Int Immunopharmacol 2004; 4: 1745-1755 (Pubitemid 39504816)
16. Vinson JA, Al Kharrat H, Andreoli L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomedicine 2005; 12: 760-765 (Pubitemid 41505333)
17. Cole L, Heard CH. Skin permeation enhancement potential of Aloe vera and a proposed mechanism of action based upon size exclusion and pull effect. Int J Pharm 2007; 333: 10-16 (Pubitemid 46283265)
18. Kotzé AF, Lueβen HL, De Leeuw BJ, De Boer AG, Verhoef JC, Junginger HE. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2). Pharm Res 1997; 14: 1197-1202
19. Junginger HE, Verhoef JC. Macromolecules as safe penetration enhancers for hydrophilic drugs: a fiction? Pharm Sci Technol Today 1998; 9: 370-376
20. Di Colo G, Zambito Y, Zaino C. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration enhancement properties, mechanism of action, safety issues. J Pharm Sci 2007; 97: 1-29
21. Thanou MM, Kotzé AF, Scharringhausen T, Luessen HL, De Boer AG, Verhoef JC, Junginger HE. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers. J Control Release 2000; 64: 15-25 (Pubitemid 30035304)
22. Borchard G, Luessen HL, De Boer AG, Verhoef JC, Lehr C-M, Junginger HE. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J Control Release 1996; 39: 131-138 (Pubitemid 26194212)
23. Schipper GM, Olsson S, Hoogstraate JA, De Boer AG, Varum KM, Artursson P. Chitosan as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm Res 1997; 14: 923-929 (Pubitemid 27326989)
24. Grabovac V, Föger F, Bernkop-Schnürch A. Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers. Int J Pharm 2008; 348: 169-174 (Pubitemid 350266233)
25. Kotzé AF, Luessen HL, De Leeuw BJ, De Boer AG, Verhoef JC, Junginger HE. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release 1998; 51: 35-46